Fintel reports that on October 30, 2025, Citigroup maintained coverage of Bio-Rad Laboratories (NYSE:BIO.B) with a Buy recommendation. Analyst Price Forecast Suggests 21.85% Upside As of April 2, 2025 ...
4 天on MSN
WESCO raises 2025 organic sales growth outlook to 8–9% with data center sales up 60% amid ...
Q3 2025 Management View John Engel, Chairman, President & CEO, stated, "We delivered very strong results in the third quarter ...
Get Q3 2025 earnings insights for Integra LifeSciences (IART): supply chain updates, financial results, guidance revisions, and outlook.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈